XRTX
NASDAQ · Pharmaceuticals
Xortx Therapeutics Inc
$0.41
+0.01 (+2.53%)
Open$0.41
Previous Close$0.40
Day High$0.42
Day Low$0.39
52W High$1.97
52W Low$0.49
Volume—
Avg Volume4.5K
Market Cap3.57M
P/E Ratio—
EPS$-0.60
SectorPharmaceuticals
Analyst Ratings
Strong Buy
5 analysts
Price Target
+10,428.4% upside
Current
$0.41
$0.41
Target
$42.64
$42.64
$28.32
$42.64 avg
$47.79
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 252.54M | 316.42M | 1.25M |
| Net Income | -4,777,407 | -5,387,377 | 338.7K |
| Profit Margin | -2.6% | -2.5% | 27.0% |
| EBITDA | -5,657,948 | -6,734,808 | 499.5K |
| Free Cash Flow | — | — | 161.5K |
| Rev Growth | -20.2% | -20.2% | +20.7% |
| Debt/Equity | 0.02 | 0.02 | 0.65 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |